April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
In vitro Microbiocidal Activity in Tears of N,N-dichloro-2,2-dimethyltaurine (NVC-422, AL-46383A), a Novel Topical Ophthalmic Agent
Author Affiliations & Notes
  • K. K. Najafi
    Eye Institute Of Marin, San Rafael, California
    NovaBay Pharmaceuticals Inc., Emeryville, California
  • S. S. Wilmarth
    NovaBay Pharmaceuticals Inc., Emeryville, California
  • R. Najafi
    NovaBay Pharmaceuticals Inc., Emeryville, California
  • B. Khosrovi
    NovaBay Pharmaceuticals Inc., Emeryville, California
  • M. Anderson
    NovaBay Pharmaceuticals Inc., Emeryville, California
  • C. Celeri
    NovaBay Pharmaceuticals Inc., Emeryville, California
  • D. Debabov
    NovaBay Pharmaceuticals Inc., Emeryville, California
  • M. Chowhan
    Alcon Laboratories, Fort Worth, Texas
  • D. W. Stroman
    Alcon Laboratories, Fort Worth, Texas
  • Footnotes
    Commercial Relationships  K.K. Najafi, NovaBay Pharmaceuticals Inc., I; NovaBay Pharmaceuticals Inc., C; NovaBay Pharmaceuticals Inc., R; S.S. Wilmarth, NovaBay Pharmaceuticals Inc, I; NovaBay Pharmaceuticals Inc., C; NovaBay Pharmaceuticals Inc, R; R. Najafi, NovaBay Pharmaceuticals Inc, I; NovaBay Pharmaceuticals Inc, E; NovaBay Pharmaceuticals Inc, P; B. Khosrovi, NovaBay Pharmaceuticals Inc., I; NovaBay Pharmaceuticals Inc., E; NovaBay Pharmaceuticals Inc., P; M. Anderson, NovaBay Pharmaceuticals Inc., I; NovaBay Pharmaceuticals Inc., E; NovaBay Pharmaceuticals Inc., P; C. Celeri, NovaBay Pharmaceuticals Inc., I; NovaBay Pharmaceuticals Inc., E; NovaBay Pharmaceuticals Inc., P; D. Debabov, NovaBay Pharmaceuticals Inc., I; NovaBay Pharmaceuticals Inc., E; NovaBay Pharmaceuticals Inc., P; M. Chowhan, Alcon Labs, I; Alcon Labs, E; Alcon Labs, P; D.W. Stroman, Alcon labs, I; Alcon Labs, E; Alcon Labs, P.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 1992. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. K. Najafi, S. S. Wilmarth, R. Najafi, B. Khosrovi, M. Anderson, C. Celeri, D. Debabov, M. Chowhan, D. W. Stroman; In vitro Microbiocidal Activity in Tears of N,N-dichloro-2,2-dimethyltaurine (NVC-422, AL-46383A), a Novel Topical Ophthalmic Agent. Invest. Ophthalmol. Vis. Sci. 2010;51(13):1992.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To evaluate the microbicidal activity and chemical stabilityin synthetic tears of N,N-dichloro-2,2-dimethyltaurine (NVC-422),which is a synthetic analog of N-chlorotaurine (NCT). NCT isa relatively longer-lived endogenous antimicrobial componentproduced during oxidative burst by neutrophils and monocytes.

 
Methods:
 

Stability of NVC-422 in 10% synthetic tears containing lysozyme,IgG, albumin and other components was tested using HPLC withUV detection. Bacterial time kill kinetics was studied in 5mM acetate saline, pH 4 and in the presence of synthetic tears.Antiviral activity was determined by incubating viruses withserial dilutions of test compounds in 5 mM acetate saline, pH4 followed by cell infection. The titer of virus was calculatedbased on the number of wells that show cytopathic effect (CPE).The TCID50 was determined from the dilution where 50% of thecultures were positive for CPE.

 
Results:
 

NVC-422 showed stability in 10% synthetic tears (97.5% remaining)after a 2 hr incubation. 0.3% NVC-422 in acetate saline pH 4in the presence of synthetic tears was bacteriocidal againstGram-positive and Gram-negative bacteria (Table1). Antiviralactivity of NVC-422 was retained in 10% synthetic tears. 0.1%NVC-422 reduced all viral titers to the limit of detection (Table2). See tables below.

 
Conclusions:
 

NVC-422 retains its chemical stability, virucidal and bactericidalactivity in presence of synthetic tears.  

 

 
Keywords: antiviral drugs • adenovirus • antibiotics/antifungals/antiparasitics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×